Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium

Long‐Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment‐Experienced Patients with Drug‐Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials

(2010) Roy T. Steigbigel et al.   CLINICAL INFECTIOUS DISEASES

Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1–Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses

(2010) Jeffrey L Lennox et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Retroviral intasome assembly and inhibition of DNA strand transfer

(2010) Stephen Hare et al.   NATURE

Lack of a Clinically Important Effect of Moderate Hepatic Insufficiency and Severe Renal Insufficiency on Raltegravir Pharmacokinetics

(2009) M. Iwamoto et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of Tipranavir-Ritonavir on Pharmacokinetics of Raltegravir

(2009) W. D. Hanley et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir

(2009) L. A. Wenning et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

(2009) Jeffrey L Lennox et al.   LANCET

Minimal Pharmacokinetic Interaction between the Human Immunodeficiency Virus Nonnucleoside Reverse Transcriptase Inhibitor Etravirine and the Integrase Inhibitor Raltegravir in Healthy Subjects

(2008) M. S. Anderson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Minimal Effects of Ritonavir and Efavirenz on the Pharmacokinetics of Raltegravir

(2008) M. Iwamoto et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Lack of a Significant Drug Interaction between Raltegravir and Tenofovir

(2008) L. A. Wenning et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Atazanavir Modestly Increases Plasma Levels of Raltegravir in Healthy Subjects

(2008) Marian Iwamoto et al.   CLINICAL INFECTIOUS DISEASES

Antiretroviral Treatment of Adult HIV Infection

(2008) Scott M. Hammer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

(2008) David A. Cooper et al.   NEW ENGLAND JOURNAL OF MEDICINE

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

(2008) Roy T. Steigbigel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lack of a Pharmacokinetic Effect of Raltegravir on Midazolam: In Vitro/In Vivo Correlation

(2007) Marian Iwamoto et al.   JOURNAL OF CLINICAL PHARMACOLOGY